Search Results for: results
LCAT Gene LCAT Deficiency Genetic Test Cost
The LCAT gene plays a crucial role in the body's metabolism of lipids. It encodes an enzyme called lecithin-cholesterol acyltransferase, which is instrumental in the process of converting cholesterol into a form that can be easily transported through the bloodstream. Mutations in the LCAT gene can lead to a condition known as LCAT deficiency, which is characterized by abnormal lipid levels in the blood, potentially leading to a range of health issues including kidney disease, corneal opacities, and anemia. To diagnose LCAT deficiency, a genetic test is conducted, which involves analyzing the patient's DNA to look for mutations in the LCAT gene. This test is crucial for confirming the diagnosis, understanding the severity of the condition, and guiding treatment decisions. In the United Arab Emirates, DNA Labs UAE offers this specialized genetic test. The cost of the test is 3200 AED. DNA Labs UAE is known for its state-of-the-art facilities and expertise in genetic testing, providing accurate and reliable results. By opting for this test at DNA Labs UAE, patients and healthcare providers can gain valuable insights into the genetic underpinnings of LCAT deficiency, facilitating timely and appropriate interventions to manage the condition effectively.
ITGB2 Gene Leukocyte Adhesion Deficiency Genetic Test Cost
The ITGB2 gene plays a critical role in the proper functioning of the immune system, particularly in the process of leukocyte (white blood cells) adhesion, which is essential for the immune response to infection. Mutations in the ITGB2 gene can lead to a condition known as Leukocyte Adhesion Deficiency (LAD), a rare, genetically inherited immune disorder. Patients with LAD suffer from severe, recurrent infections from early childhood due to their immune cells' inability to properly adhere to blood vessel walls and migrate to sites of infection. To diagnose this condition, a genetic test targeting the ITGB2 gene can be conducted. This test involves analyzing the patient's DNA to identify any mutations in the ITGB2 gene that are known to cause LAD. Identifying the specific mutation can help in confirming the diagnosis, understanding the disease's severity, and guiding treatment decisions. In the United Arab Emirates, DNA Labs UAE offers this specialized genetic test for ITGB2 gene mutations. The cost of the test is 4400 AED. Conducting this test at DNA Labs UAE ensures that patients receive accurate and reliable results, thanks to the lab's adherence to high standards of genetic testing and its use of the latest technology in the field. This test is a crucial step for families affected by or suspected of having Leukocyte Adhesion Deficiency, providing them with essential information for managing the condition.
AGPAT2 Gene Lipodystrophy Generalized Type 1 Genetic Test Cost
The AGPAT2 Gene Lipodystrophy Generalized Type 1 Genetic Test is a specialized diagnostic examination offered by DNA Labs UAE, designed to identify mutations in the AGPAT2 gene, which are known to cause Generalized Lipodystrophy Type 1. This condition, also referred to as Berardinelli-Seip congenital lipodystrophy, is characterized by the near absence of adipose tissue from birth or early infancy, leading to a range of metabolic complications such as insulin resistance, diabetes, hypertriglyceridemia, and fatty liver disease. The test plays a crucial role in the early detection and management of the condition, enabling healthcare providers to tailor treatment and management plans to the individual needs of the patient. The process involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory to detect any abnormalities or mutations in the AGPAT2 gene. This gene plays a significant role in the development and function of adipose tissue, and mutations can severely impact the body's ability to store fat, leading to the symptoms associated with lipodystrophy. The cost of the AGPAT2 Gene Lipodystrophy Generalized Type 1 Genetic Test at DNA Labs UAE is set at 4400 AED. This price reflects the specialized nature of the test and the sophisticated technology and expertise required to accurately identify mutations in the AGPAT2 gene. For patients suspected of having Generalized Lipodystrophy Type 1, or for those with a family history of the condition, this test offers a valuable tool for diagnosis and subsequent management, helping to improve quality of life and reduce the risk of associated health complications.
BSCL2 Gene Lipodystrophy Generalized Type 2 Genetic Test Cost
The BSCL2 Gene Lipodystrophy Generalized Type 2 Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the BSCL2 gene, which are known to cause Generalized Lipodystrophy Type 2, also referred to as Berardinelli-Seip Congenital Lipodystrophy Type 2. This condition is characterized by a near-total lack of body fat from birth or early childhood, which can lead to a range of metabolic issues, including insulin resistance, diabetes, high triglycerides, and liver abnormalities. The test is conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing capabilities. By analyzing a sample of the patient's DNA, the test can pinpoint specific genetic mutations in the BSCL2 gene, providing crucial information for diagnosis, management, and treatment planning for affected individuals. The cost of the BSCL2 Gene Lipodystrophy Generalized Type 2 Genetic Test is set at 4400 AED. While the price may seem significant, the value of the insights gained from this test can be invaluable for patients and their families. It not only aids in confirming the diagnosis but also helps in understanding the risk of passing the condition on to future generations, thereby facilitating informed decisions regarding family planning.
CAVIN1 Gene Lipodystrophy Generalized Type 4 Genetic Test Cost
The CAVIN1 Gene Lipodystrophy Generalized Type 4 Genetic Test is a specialized diagnostic procedure designed to detect mutations in the CAVIN1 gene, which are associated with Generalized Lipodystrophy Type 4. This condition is a rare genetic disorder characterized by the near-total loss of body fat, metabolic complications such as diabetes, high levels of triglycerides in the blood, and liver abnormalities. Early and accurate diagnosis through genetic testing is crucial for managing symptoms, implementing appropriate treatments, and providing genetic counseling. Performed at DNA Labs UAE, a reputable facility known for its advanced genetic testing services, this test involves analyzing the patient's DNA to identify any mutations in the CAVIN1 gene. The process is meticulous and requires sophisticated technology and expertise, ensuring high accuracy and reliability of results. The cost of the CAVIN1 Gene Lipodystrophy Generalized Type 4 Genetic Test is 4400 AED. This investment covers the comprehensive analysis and detailed reporting necessary for diagnosing this rare condition. With the results from this test, healthcare providers can offer targeted treatment strategies, lifestyle recommendations, and support for individuals and families affected by Generalized Lipodystrophy Type 4, paving the way for improved quality of life and health outcomes.
LMNA Gene Lipodystrophy Type 2 Familial Partial Genetic Test Cost
The LMNA Gene Lipodystrophy Type 2 Familial Partial Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at detecting mutations in the LMNA gene, which are associated with Familial Partial Lipodystrophy Type 2 (FPLD2). FPLD2 is a rare genetic disorder characterized by the abnormal distribution of fat in the body, leading to a loss of subcutaneous fat in the limbs and trunk, while excess fat may accumulate in other areas, such as the face and neck. This condition can also lead to a variety of metabolic abnormalities, including insulin resistance, diabetes, hypertriglyceridemia, and an increased risk of cardiovascular disease. The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to identify any mutations in the LMNA gene. A positive result indicates a mutation in the LMNA gene that is known to cause FPLD2, providing crucial information for the diagnosis and management of the condition. This test is particularly useful for individuals showing symptoms of lipodystrophy or those with a family history of the condition, as it helps in confirming the diagnosis and facilitating early intervention strategies. The cost of the LMNA Gene Lipodystrophy Type 2 Familial Partial Genetic Test at DNA Labs UAE is 4400 AED. Given the complexity of the genetic analysis and the specialized technology required, this cost reflects the comprehensive nature of the test, ensuring accurate and reliable results. Individuals considering this test are encouraged to consult with a healthcare professional or genetic counselor to understand the implications of the test results and the best course of action based on those results.
PPARG Gene Lipodystrophy Familial Partial Type 3 Genetic Test Cost
The "PPARG Gene Lipodystrophy Familial Partial Type 3 Genetic Test" is a specialized diagnostic assessment conducted to identify mutations in the PPARG gene, which are associated with Familial Partial Lipodystrophy Type 3 (FPLD3). This condition is a rare genetic disorder characterized by the abnormal distribution of fat in the body, leading to a lack of fat in the arms and legs and excessive fat deposition in the central body. It can also predispose individuals to various metabolic complications such as diabetes, high cholesterol, and liver abnormalities. Performed at DNA Labs UAE, this test is crucial for individuals with a family history of FPLD3 or those exhibiting symptoms suggestive of the condition. By analyzing the genetic makeup through a blood sample or cheek swab, the test aims to detect specific mutations in the PPARG gene that are indicative of the disorder. The outcome of this test not only aids in the accurate diagnosis of FPLD3 but also helps in the formulation of a personalized treatment plan to manage the symptoms and prevent the onset of related metabolic complications. The cost of the PPARG Gene Lipodystrophy Familial Partial Type 3 Genetic Test at DNA Labs UAE is 4400 AED. Given the complexity of the analysis and the specialized technology employed, the test is priced to reflect the intricate processes involved in providing a definitive diagnosis. Individuals considering this test are encouraged to consult with a healthcare provider to understand its benefits, implications, and the next steps following the diagnosis.
LPA Gene LPA Deficiency Congenital Genetic Test Cost
The LPA gene is crucial for the production of lipoprotein(a), a type of low-density lipoprotein (LDL) often referred to as "bad cholesterol." Variations or mutations in the LPA gene can lead to either elevated levels of lipoprotein(a), increasing the risk of cardiovascular diseases, or LPA deficiency, which is less common and has varying implications on health. LPA deficiency is a congenital condition, meaning it is present from birth and is inherited in a genetic manner. Individuals with this deficiency might have lower risks of cardiovascular diseases, but the full implications of this condition are not completely understood and can vary widely among affected individuals. To diagnose this condition, a specific genetic test can be conducted. In the UAE, DNA Labs offers a comprehensive genetic test targeting the LPA gene to identify mutations or variations that might indicate LPA deficiency or other related conditions. The test is priced at 4400 AED. It is a crucial tool for individuals with a family history of cardiovascular diseases or those who have personal health concerns related to cholesterol and heart health. The test involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory for specific genetic markers associated with the LPA gene. Understanding one's genetic predisposition to LPA deficiency or elevated lipoprotein(a) levels can be an important step in managing and mitigating potential health risks, allowing for personalized medical advice and interventions.
